Related Experiment Video
Updated: Nov 19, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Inhaled corticosteroids may have a protective effect against coronavirus infection
Alicia Armentia1, Sara Fernández Cortés2, Angela Moro Simón2
1Allergy Service, Hospital Universitario Río Hortega, Valladolid University, Valladolid, Spain; aliciaarmentia@gmail.com.
Inhaled corticosteroids may improve outcomes for COVID-19 patients, particularly those with asthma or in nursing homes. Allergies might offer some protection against coronavirus infection.
Area of Science:
- Pulmonology
- Infectious Diseases
- Epidemiology
Background:
- Spain experienced a severe COVID-19 epidemic, with significant mortality.
- Vulnerable populations, including the elderly with pre-existing conditions, faced the highest risk.
Purpose of the Study:
- To compare respiratory symptoms in nursing home residents and patients with uncontrolled asthma.
- To assess the vulnerability of these groups to COVID-19.
Main Methods:
- A study involving 134 nursing home residents and 139 patients with uncontrolled asthma.
- Data collection included demographics, clinical data, outcomes, lab results, and radiological images.
- COVID-19 infection was confirmed via polymerase chain reaction (PCR).
Main Results:
- COVID-19 infection occurred in 9.3% of uncontrolled asthma patients, all using inhaled corticosteroids.
- Infection affected 60% of nursing home residents, with 28 (using inhaled corticosteroids) showing good prognosis.
Conclusions:
- Early treatment with inhaled corticosteroids may be beneficial for COVID-19 patients.
- Individuals with allergies may possess protective mechanisms against coronavirus.
More Related Videos
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Inhaled Medications
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...